4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-096061
Options or other derivatives
- SVP & Chief Medical Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gergel Ivan P. · SVP & Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-02-03 | Grant or award : show line 1 in the form Stock Option | +100,000 | $12.21 | 2024-02-02 | 100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…